Literature DB >> 8045245

The diagnostic value of multi-modality evoked potentials in Wilson's disease.

G Arendt1, H Hefter, W Stremmel, G Strohmeyer.   

Abstract

19 patients with a neurological manifestation of Wilson's disease (WD), most of them with long-term disease (> 10 yr), underwent clinical, psychometrical and electrophysiological evaluation in order to test whether there is a correlation of psychometrical and evoked potential (EP) abnormalities with a semiquantitative clinical score ranging from no (0) to severe (3) symptoms. The following EPs were recorded: acoustically evoked event-related (ERPs), somato-sensory (SSEPs), visually (VEPs) and brainstem evoked potentials (BSEPs). Results were compared with the data of an age- and sex-matched control group. 89% of the patients revealed clinical signs of basal ganglia dysfunction, 11% oculomotor or cerebellar symptoms, but none of the individuals had any clinical hint for visual pathway affection. Psychometrically, 100% had mood disturbances without definite intellectual decline. In EP-recordings, 100% showed ERP, 58.0% SSEP and 53% VEP and BSEP abnormalities. VEP and BSEP measurements did not correlate with the clinical score. There was only a weak correlation of SSEP (right-side)- and ERP-amplitude reduction with the clinical total score. The only significant correlation was found between the clinical total score and the time dependent psychometrical tests. Thus, there is a fairly high percentage of subclinical cerebral impairment in Wilson patients with long-term disease detectable by ERP-recordings which do, however, not correlate with the clinical status of the patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045245

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  3 in total

1.  [Electrophysiological impairment profile of patients with Wilson's disease].

Authors:  W Hermann; T Villmann; A Wagner
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

2.  Quality of Life and Psychiatric Symptoms in Wilson's Disease: the Relevance of Bipolar Disorders.

Authors:  Mg Carta; G Mura; O Sorbello; G Farina; L Demelia
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-09-18

3.  Retinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography.

Authors:  Philipp Albrecht; Ann-Kristin Müller; Marius Ringelstein; David Finis; Gerd Geerling; Eva Cohn; Orhan Aktas; Hans-Peter Hartung; Harald Hefter; Axel Methner
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.